Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,147
Closed -$417K 175
2024
Q1
$417K Hold
1,147
0.15% 122
2023
Q4
$343K Sell
1,147
-16
-1% -$4.68K 0.14% 132
2023
Q3
$333K Buy
1,163
+75
+7% +$21.4K 0.15% 127
2023
Q2
$305K Hold
1,088
0.13% 142
2023
Q1
$278K Sell
1,088
-15
-1% -$4.37K 0.13% 149
2022
Q4
$365K Sell
1,103
-176
-14% -$55.7K 0.17% 126
2022
Q3
$355K Sell
1,279
-200
-14% -$56.3K 0.19% 119
2022
Q2
$390K Sell
1,479
-175
-11% -$45.1K 0.2% 116
2022
Q1
$396K Buy
1,654
+75
+5% +$17.6K 0.19% 123
2021
Q4
$363K Buy
1,579
+523
+50% +$111K 0.17% 122
2021
Q3
$211K Buy
1,056
+181
+21% +$39.4K 0.11% 151
2021
Q2
$207K Buy
+875
New +$219K 0.1% 152

Other funds holding CI

LCNB Corp's CI Position: Q2 2024 in Review

LCNB Corp sold out of Cigna (CI) in Q2 2024, closing a stake of 1,147 shares — an estimated $417K sold.

LCNB Corp first reported a position in CI in Q2 2021 and held it in 12 quarters. The position peaked at $417K in Q1 2024. 1,663 funds tracked by Wall St. Rank hold CI as of Q2 2024.

  • LCNB Corp reported no remaining Cigna position as of Q2 2024 after selling out during the quarter.
  • LCNB Corp sold 1,147 Cigna shares in Q2 2024, an estimated $417K.
  • LCNB Corp first reported a position in Cigna in Q2 2021 and held it in 12 quarters.
  • LCNB Corp's Cigna position peaked at $417K in Q1 2024.
  • 1,663 funds tracked by Wall St. Rank held Cigna as of Q2 2024.

Based on LCNB Corp's 13F filing for Q2 2024, filed 14 Aug 2024.